Rank | Gene Set | Z-score |
---|---|---|
1 | daunorubicin metabolic process (GO:0044597) | 8.47144858 |
2 | polyketide metabolic process (GO:0030638) | 8.47144858 |
3 | doxorubicin metabolic process (GO:0044598) | 8.47144858 |
4 | protein localization to kinetochore (GO:0034501) | 6.71383029 |
5 | maintenance of protein location in nucleus (GO:0051457) | 6.06026360 |
6 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.56922938 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.56139496 |
8 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.37159552 |
9 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.36386345 |
10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.34955122 |
11 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.32407508 |
12 | mitotic sister chromatid segregation (GO:0000070) | 5.18640580 |
13 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.14307846 |
14 | protein localization to chromosome, centromeric region (GO:0071459) | 5.10919520 |
15 | negative regulation of epidermis development (GO:0045683) | 5.09035343 |
16 | somite rostral/caudal axis specification (GO:0032525) | 5.00324073 |
17 | negative regulation of telomerase activity (GO:0051974) | 4.98685486 |
18 | regulation of response to osmotic stress (GO:0047484) | 4.78404164 |
19 | rRNA transcription (GO:0009303) | 4.74223104 |
20 | heterochromatin organization (GO:0070828) | 4.70159447 |
21 | histone H4-K5 acetylation (GO:0043981) | 4.64555303 |
22 | histone H4-K8 acetylation (GO:0043982) | 4.64555303 |
23 | histone H4-K12 acetylation (GO:0043983) | 4.61611462 |
24 | DNA replication checkpoint (GO:0000076) | 4.60567681 |
25 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.60278882 |
26 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.60278882 |
27 | muscle organ morphogenesis (GO:0048644) | 4.60218910 |
28 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.51320911 |
29 | neutrophil activation involved in immune response (GO:0002283) | 4.48245129 |
30 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.47645113 |
31 | sister chromatid segregation (GO:0000819) | 4.46675197 |
32 | negative regulation of cell killing (GO:0031342) | 4.44041235 |
33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.44041235 |
34 | nuclear pore complex assembly (GO:0051292) | 4.40211103 |
35 | negative regulation of interleukin-12 production (GO:0032695) | 4.34668981 |
36 | cellular extravasation (GO:0045123) | 4.34088201 |
37 | regulation of translation in response to stress (GO:0043555) | 4.32413037 |
38 | positive regulation by symbiont of host defense response (GO:0052509) | 4.19780438 |
39 | modulation by symbiont of host defense response (GO:0052031) | 4.19780438 |
40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.19780438 |
41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.19780438 |
42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.19780438 |
43 | modulation by symbiont of host immune response (GO:0052553) | 4.19780438 |
44 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.18543058 |
45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.18288423 |
46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.17464289 |
47 | chromatin assembly (GO:0031497) | 4.13319582 |
48 | immunoglobulin mediated immune response (GO:0016064) | 4.11581959 |
49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.97767107 |
50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96869041 |
51 | nuclear pore organization (GO:0006999) | 3.94562257 |
52 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.93548983 |
53 | negative regulation of telomere maintenance (GO:0032205) | 3.91722960 |
54 | interferon-gamma production (GO:0032609) | 3.91402113 |
55 | notochord development (GO:0030903) | 3.87588725 |
56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83320516 |
57 | rRNA methylation (GO:0031167) | 3.80991716 |
58 | detection of other organism (GO:0098543) | 3.78610299 |
59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.71630006 |
60 | response to muramyl dipeptide (GO:0032495) | 3.69268583 |
61 | macrophage activation involved in immune response (GO:0002281) | 3.67906280 |
62 | positive regulation of protein deacetylation (GO:0090312) | 3.66921439 |
63 | maintenance of protein localization in organelle (GO:0072595) | 3.66677304 |
64 | DNA unwinding involved in DNA replication (GO:0006268) | 3.64095570 |
65 | mitotic chromosome condensation (GO:0007076) | 3.63896153 |
66 | rRNA modification (GO:0000154) | 3.63728298 |
67 | detection of bacterium (GO:0016045) | 3.60449796 |
68 | histone H4-K16 acetylation (GO:0043984) | 3.58765298 |
69 | positive regulation of B cell differentiation (GO:0045579) | 3.57607366 |
70 | mRNA stabilization (GO:0048255) | 3.56971269 |
71 | RNA stabilization (GO:0043489) | 3.56971269 |
72 | defense response to protozoan (GO:0042832) | 3.53401033 |
73 | hormone catabolic process (GO:0042447) | 3.52574818 |
74 | primitive streak formation (GO:0090009) | 3.51346820 |
75 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50717394 |
76 | cytidine deamination (GO:0009972) | 3.50701244 |
77 | cytidine metabolic process (GO:0046087) | 3.50701244 |
78 | cytidine catabolic process (GO:0006216) | 3.50701244 |
79 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.49798029 |
80 | T cell migration (GO:0072678) | 3.49778388 |
81 | DNA duplex unwinding (GO:0032508) | 3.46851585 |
82 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46812519 |
83 | pre-miRNA processing (GO:0031054) | 3.45666066 |
84 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.42948998 |
85 | regulation of mast cell degranulation (GO:0043304) | 3.42847680 |
86 | nucleoside transmembrane transport (GO:1901642) | 3.42754085 |
87 | DNA geometric change (GO:0032392) | 3.41882649 |
88 | positive regulation of histone deacetylation (GO:0031065) | 3.37432200 |
89 | maternal placenta development (GO:0001893) | 3.33011528 |
90 | response to protozoan (GO:0001562) | 3.32741458 |
91 | formation of translation preinitiation complex (GO:0001731) | 3.32216704 |
92 | leukocyte aggregation (GO:0070486) | 3.31193397 |
93 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.30912965 |
94 | pentose-phosphate shunt (GO:0006098) | 3.26843178 |
95 | B cell receptor signaling pathway (GO:0050853) | 3.25135630 |
96 | pore complex assembly (GO:0046931) | 3.24294561 |
97 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.23078661 |
98 | B cell mediated immunity (GO:0019724) | 3.20629487 |
99 | trophectodermal cell differentiation (GO:0001829) | 3.20083178 |
100 | respiratory burst (GO:0045730) | 3.19601917 |
101 | ribosome biogenesis (GO:0042254) | 3.19402004 |
102 | negative regulation of phagocytosis (GO:0050765) | 3.18712621 |
103 | myeloid cell activation involved in immune response (GO:0002275) | 3.18349642 |
104 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17713150 |
105 | detection of external biotic stimulus (GO:0098581) | 3.17168622 |
106 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15712688 |
107 | apoptotic DNA fragmentation (GO:0006309) | 3.15134569 |
108 | neutrophil activation (GO:0042119) | 3.13877902 |
109 | negative thymic T cell selection (GO:0045060) | 3.13795204 |
110 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.13436987 |
111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13051584 |
112 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.12797712 |
113 | regulation of leukocyte degranulation (GO:0043300) | 3.12277490 |
114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10361986 |
115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.10313018 |
116 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.09929884 |
117 | neutrophil mediated immunity (GO:0002446) | 3.09695461 |
118 | regulation of B cell differentiation (GO:0045577) | 3.09411540 |
119 | regulation of cilium movement (GO:0003352) | 3.08257861 |
120 | regulation of telomere maintenance (GO:0032204) | 3.07698969 |
121 | granulocyte activation (GO:0036230) | 3.07615757 |
122 | retinoic acid receptor signaling pathway (GO:0048384) | 3.07449135 |
123 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.06874004 |
124 | phenol-containing compound catabolic process (GO:0019336) | 3.05200305 |
125 | positive thymic T cell selection (GO:0045059) | 3.04769867 |
126 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03939082 |
127 | germinal center formation (GO:0002467) | 3.03886213 |
128 | DNA replication initiation (GO:0006270) | 3.03749446 |
129 | DNA damage response, detection of DNA damage (GO:0042769) | 3.03642107 |
130 | detection of molecule of bacterial origin (GO:0032490) | 3.03137010 |
131 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02892442 |
132 | response to host immune response (GO:0052572) | 3.02651117 |
133 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02651117 |
134 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01081108 |
135 | regulation of telomerase activity (GO:0051972) | 3.00910405 |
136 | cellular response to type I interferon (GO:0071357) | 2.99991464 |
137 | type I interferon signaling pathway (GO:0060337) | 2.99991464 |
138 | response to type I interferon (GO:0034340) | 2.99255971 |
139 | coenzyme catabolic process (GO:0009109) | 2.97545623 |
140 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.97179260 |
141 | negative T cell selection (GO:0043383) | 2.95901444 |
142 | regulation of gene silencing by RNA (GO:0060966) | 2.95397422 |
143 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.95397422 |
144 | regulation of gene silencing by miRNA (GO:0060964) | 2.95397422 |
145 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94771236 |
146 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.93966612 |
147 | regulation of antigen processing and presentation (GO:0002577) | 2.93897560 |
148 | NIK/NF-kappaB signaling (GO:0038061) | 2.93657332 |
149 | microglial cell activation (GO:0001774) | 2.93606213 |
150 | positive regulation of mast cell activation (GO:0033005) | 2.92708499 |
151 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.92622066 |
152 | response to peptidoglycan (GO:0032494) | 2.92551771 |
153 | quinone metabolic process (GO:1901661) | 2.92292766 |
154 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92167054 |
155 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.91991606 |
156 | spindle assembly (GO:0051225) | 2.90398356 |
157 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89701940 |
158 | cellular modified amino acid catabolic process (GO:0042219) | 2.88319412 |
159 | response to dietary excess (GO:0002021) | 2.87251033 |
160 | positive regulation of granulocyte differentiation (GO:0030854) | 2.87175927 |
161 | regulation of mast cell activation (GO:0033003) | 2.87174705 |
162 | regulation of double-strand break repair (GO:2000779) | 2.86895552 |
163 | intestinal epithelial cell development (GO:0060576) | 2.83927491 |
164 | detection of biotic stimulus (GO:0009595) | 2.83899472 |
165 | response to host (GO:0075136) | 2.83738730 |
166 | response to host defenses (GO:0052200) | 2.83738730 |
167 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83738730 |
168 | primary alcohol catabolic process (GO:0034310) | 2.83728067 |
169 | adaptation of signaling pathway (GO:0023058) | 2.83452299 |
170 | positive regulation of interferon-alpha production (GO:0032727) | 2.83246391 |
171 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.83165950 |
172 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.83165950 |
173 | mitochondrial DNA replication (GO:0006264) | 2.82743646 |
174 | regulation of tolerance induction (GO:0002643) | 2.82038628 |
175 | pseudouridine synthesis (GO:0001522) | 2.81588625 |
176 | regulation of interferon-alpha production (GO:0032647) | 2.81415534 |
177 | NADPH regeneration (GO:0006740) | 2.81245486 |
178 | macrophage activation (GO:0042116) | 2.80888240 |
179 | defense response to fungus (GO:0050832) | 2.80393918 |
180 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.80097111 |
181 | T cell selection (GO:0045058) | 2.78966238 |
182 | T-helper 1 type immune response (GO:0042088) | 2.78308932 |
183 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.78286606 |
184 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77444471 |
185 | positive regulation of mast cell degranulation (GO:0043306) | 2.77444471 |
186 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76622891 |
187 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.76386991 |
188 | response to interleukin-15 (GO:0070672) | 2.76068186 |
189 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.75706089 |
190 | regulation of T cell tolerance induction (GO:0002664) | 2.74264864 |
191 | positive regulation of isotype switching (GO:0045830) | 2.72806161 |
192 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.71540485 |
193 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70516041 |
194 | negative regulation of innate immune response (GO:0045824) | 2.69250294 |
195 | negative regulation of interleukin-6 production (GO:0032715) | 2.68617427 |
196 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67929486 |
197 | leukocyte degranulation (GO:0043299) | 2.66996641 |
198 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.66102508 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.30675385 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.48803531 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.06477639 |
4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.84612851 |
5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.84612851 |
6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.84612851 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.70218289 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45160177 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.37683054 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27812101 |
11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.20485837 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17208235 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98847993 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.97844375 |
15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.85832740 |
16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83556229 |
17 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.75655331 |
18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67850779 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58929736 |
20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57874068 |
21 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.44584318 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.42894970 |
23 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.40949026 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.39786175 |
25 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.37637402 |
26 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.32864018 |
27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.29403418 |
28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.28237422 |
29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25308560 |
30 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.19472986 |
31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18170069 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 2.12150619 |
33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10655094 |
34 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.07858892 |
35 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.98641257 |
36 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.97538280 |
37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97216129 |
38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96847816 |
39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92447926 |
40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.90583594 |
41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90254836 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.88353632 |
43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87540557 |
44 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.82860748 |
45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.81917469 |
46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79920218 |
47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73596703 |
48 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72669406 |
49 | MAF_26560356_Chip-Seq_TH2_Human | 1.70019280 |
50 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.69977289 |
51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.65427822 |
52 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65368219 |
53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.64043282 |
54 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.63909869 |
55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61128668 |
56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53689690 |
57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51256762 |
58 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.51034001 |
59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50405825 |
60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48724608 |
61 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48262677 |
62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.48157022 |
63 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.47208088 |
64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46072152 |
65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45842204 |
66 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.45282928 |
67 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44598878 |
68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43478853 |
69 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.42621466 |
70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42233520 |
71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41997121 |
72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37846605 |
73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37275888 |
74 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36946348 |
75 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.36336725 |
76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35041382 |
77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34447426 |
78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33452407 |
79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33416607 |
80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32711314 |
81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32408313 |
82 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32361992 |
83 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32199836 |
84 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.31473765 |
85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30530355 |
86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29581666 |
87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24977974 |
88 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.23792419 |
89 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23507350 |
90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22970343 |
91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21260390 |
92 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20554910 |
93 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.18482896 |
94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17159811 |
95 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.15643377 |
96 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15386360 |
97 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14900547 |
98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14808264 |
99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14764980 |
100 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13879270 |
101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13790249 |
102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13610103 |
103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13378134 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12971737 |
105 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.12635629 |
106 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12603408 |
107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12232228 |
108 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12159105 |
109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11699852 |
110 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11487130 |
111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10824245 |
112 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10704419 |
113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09750144 |
114 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09237231 |
115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08965222 |
116 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07998765 |
117 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07847173 |
118 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.07610713 |
119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06583225 |
120 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06465087 |
121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05220481 |
122 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.05114820 |
123 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04909022 |
124 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.04412034 |
125 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03184688 |
126 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.03106298 |
127 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02711362 |
128 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.01555114 |
129 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01247807 |
130 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00987569 |
131 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.00454309 |
132 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.99982479 |
133 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.99157152 |
134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99053821 |
135 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98194582 |
136 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.97518470 |
137 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97327527 |
138 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97028154 |
139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97014780 |
140 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96932690 |
141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96547304 |
142 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96193399 |
143 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95630237 |
144 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94893376 |
145 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94742489 |
146 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.93887694 |
147 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92720997 |
148 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91669111 |
149 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.91400228 |
150 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91393064 |
151 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91134808 |
152 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90672596 |
153 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90237192 |
154 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.89862617 |
155 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88952916 |
156 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87773188 |
157 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.87768600 |
158 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86927199 |
159 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86819554 |
160 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86785432 |
161 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86585604 |
162 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.85312963 |
163 | MYB_26560356_Chip-Seq_TH1_Human | 0.84960620 |
164 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84431541 |
165 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84321001 |
166 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84033496 |
167 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83439821 |
168 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83270098 |
169 | MAF_26560356_Chip-Seq_TH1_Human | 0.83062275 |
170 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82928196 |
171 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82757489 |
172 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.82729152 |
173 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82487198 |
174 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.82222810 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.93548978 |
2 | MP0004264_abnormal_extraembryonic_tissu | 3.89438470 |
3 | MP0003011_delayed_dark_adaptation | 3.58691344 |
4 | MP0002254_reproductive_system_inflammat | 3.56340984 |
5 | MP0008057_abnormal_DNA_replication | 3.28728980 |
6 | MP0004957_abnormal_blastocyst_morpholog | 3.17939424 |
7 | MP0003724_increased_susceptibility_to | 3.10959515 |
8 | MP0002419_abnormal_innate_immunity | 2.92374429 |
9 | MP0005671_abnormal_response_to | 2.91450385 |
10 | MP0006292_abnormal_olfactory_placode | 2.90676101 |
11 | MP0005000_abnormal_immune_tolerance | 2.80978395 |
12 | MP0003890_abnormal_embryonic-extraembry | 2.80235037 |
13 | MP0000685_abnormal_immune_system | 2.79014187 |
14 | MP0005075_abnormal_melanosome_morpholog | 2.78545725 |
15 | MP0005387_immune_system_phenotype | 2.75453769 |
16 | MP0001790_abnormal_immune_system | 2.75453769 |
17 | MP0005025_abnormal_response_to | 2.71543825 |
18 | MP0010352_gastrointestinal_tract_polyps | 2.70516411 |
19 | MP0003705_abnormal_hypodermis_morpholog | 2.67790143 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.56063949 |
21 | MP0002452_abnormal_antigen_presenting | 2.53732765 |
22 | MP0005058_abnormal_lysosome_morphology | 2.52724926 |
23 | MP0002723_abnormal_immune_serum | 2.48549019 |
24 | MP0003183_abnormal_peptide_metabolism | 2.45800761 |
25 | MP0002420_abnormal_adaptive_immunity | 2.40176761 |
26 | MP0003172_abnormal_lysosome_physiology | 2.39919002 |
27 | MP0001819_abnormal_immune_cell | 2.38943039 |
28 | MP0003300_gastrointestinal_ulcer | 2.31176675 |
29 | MP0003763_abnormal_thymus_physiology | 2.28198662 |
30 | MP0005394_taste/olfaction_phenotype | 2.22043053 |
31 | MP0005499_abnormal_olfactory_system | 2.22043053 |
32 | MP0004858_abnormal_nervous_system | 2.20508721 |
33 | MP0003191_abnormal_cellular_cholesterol | 2.12883442 |
34 | MP0002396_abnormal_hematopoietic_system | 2.11472678 |
35 | MP0003077_abnormal_cell_cycle | 2.03862387 |
36 | MP0003121_genomic_imprinting | 2.03562669 |
37 | MP0002332_abnormal_exercise_endurance | 2.01071971 |
38 | MP0003123_paternal_imprinting | 1.99605586 |
39 | MP0005464_abnormal_platelet_physiology | 1.97826869 |
40 | MP0003111_abnormal_nucleus_morphology | 1.95912194 |
41 | MP0003122_maternal_imprinting | 1.89886052 |
42 | MP0009840_abnormal_foam_cell | 1.88767085 |
43 | MP0004947_skin_inflammation | 1.88011228 |
44 | MP0005380_embryogenesis_phenotype | 1.86678010 |
45 | MP0001672_abnormal_embryogenesis/_devel | 1.86678010 |
46 | MP0010155_abnormal_intestine_physiology | 1.82831273 |
47 | MP0002653_abnormal_ependyma_morphology | 1.82744109 |
48 | MP0001533_abnormal_skeleton_physiology | 1.82282766 |
49 | MP0003693_abnormal_embryo_hatching | 1.79643563 |
50 | MP0006035_abnormal_mitochondrial_morpho | 1.79150732 |
51 | MP0005451_abnormal_body_composition | 1.78750252 |
52 | MP0000350_abnormal_cell_proliferation | 1.78402845 |
53 | MP0002088_abnormal_embryonic_growth/wei | 1.75319785 |
54 | MP0003984_embryonic_growth_retardation | 1.75236915 |
55 | MP0010094_abnormal_chromosome_stability | 1.75025433 |
56 | MP0009333_abnormal_splenocyte_physiolog | 1.74059932 |
57 | MP0003436_decreased_susceptibility_to | 1.73613078 |
58 | MP0001845_abnormal_inflammatory_respons | 1.72340961 |
59 | MP0005257_abnormal_intraocular_pressure | 1.63486186 |
60 | MP0000465_gastrointestinal_hemorrhage | 1.56322977 |
61 | MP0001873_stomach_inflammation | 1.54752277 |
62 | MP0002277_abnormal_respiratory_mucosa | 1.54254895 |
63 | MP0009764_decreased_sensitivity_to | 1.50794715 |
64 | MP0005310_abnormal_salivary_gland | 1.49990554 |
65 | MP0000490_abnormal_crypts_of | 1.49972768 |
66 | MP0008469_abnormal_protein_level | 1.49033051 |
67 | MP0008961_abnormal_basal_metabolism | 1.48684564 |
68 | MP0008260_abnormal_autophagy | 1.48671794 |
69 | MP0002086_abnormal_extraembryonic_tissu | 1.47534384 |
70 | MP0005023_abnormal_wound_healing | 1.46655100 |
71 | MP0000678_abnormal_parathyroid_gland | 1.42596520 |
72 | MP0002166_altered_tumor_susceptibility | 1.41283852 |
73 | MP0002998_abnormal_bone_remodeling | 1.35673282 |
74 | MP0001849_ear_inflammation | 1.33626065 |
75 | MP0001293_anophthalmia | 1.32617126 |
76 | MP0002085_abnormal_embryonic_tissue | 1.29557974 |
77 | MP0001730_embryonic_growth_arrest | 1.29093492 |
78 | MP0006082_CNS_inflammation | 1.28592229 |
79 | MP0003656_abnormal_erythrocyte_physiolo | 1.28208345 |
80 | MP0002932_abnormal_joint_morphology | 1.24159539 |
81 | MP0002092_abnormal_eye_morphology | 1.21652692 |
82 | MP0003303_peritoneal_inflammation | 1.21423877 |
83 | MP0003075_altered_response_to | 1.20071837 |
84 | MP0004197_abnormal_fetal_growth/weight/ | 1.19774638 |
85 | MP0000858_altered_metastatic_potential | 1.18983782 |
86 | MP0003938_abnormal_ear_development | 1.17446229 |
87 | MP0000313_abnormal_cell_death | 1.16925480 |
88 | MP0000604_amyloidosis | 1.15600915 |
89 | MP0002084_abnormal_developmental_patter | 1.13684647 |
90 | MP0010030_abnormal_orbit_morphology | 1.13632780 |
91 | MP0003866_abnormal_defecation | 1.11491000 |
92 | MP0009278_abnormal_bone_marrow | 1.10270616 |
93 | MP0001697_abnormal_embryo_size | 1.10052678 |
94 | MP0002006_tumorigenesis | 1.06427450 |
95 | MP0002009_preneoplasia | 1.06397608 |
96 | MP0003566_abnormal_cell_adhesion | 1.06123912 |
97 | MP0000343_altered_response_to | 1.05270561 |
98 | MP0002080_prenatal_lethality | 1.04656332 |
99 | MP0002970_abnormal_white_adipose | 1.04651336 |
100 | MP0002405_respiratory_system_inflammati | 1.04082548 |
101 | MP0008932_abnormal_embryonic_tissue | 1.03575190 |
102 | MP0005266_abnormal_metabolism | 1.03331525 |
103 | MP0002127_abnormal_cardiovascular_syste | 1.02556998 |
104 | MP0008004_abnormal_stomach_pH | 0.99781920 |
105 | MP0001851_eye_inflammation | 0.98936909 |
106 | MP0002019_abnormal_tumor_incidence | 0.98024805 |
107 | MP0005164_abnormal_response_to | 0.95605082 |
108 | MP0003448_altered_tumor_morphology | 0.94900031 |
109 | MP0002722_abnormal_immune_system | 0.94120807 |
110 | MP0000689_abnormal_spleen_morphology | 0.93908446 |
111 | MP0004808_abnormal_hematopoietic_stem | 0.93308388 |
112 | MP0004381_abnormal_hair_follicle | 0.93227383 |
113 | MP0002132_abnormal_respiratory_system | 0.92920492 |
114 | MP0009763_increased_sensitivity_to | 0.90176215 |
115 | MP0004883_abnormal_blood_vessel | 0.90005321 |
116 | MP0005166_decreased_susceptibility_to | 0.89389616 |
117 | MP0002925_abnormal_cardiovascular_devel | 0.89368730 |
118 | MP0001545_abnormal_hematopoietic_system | 0.88102843 |
119 | MP0005397_hematopoietic_system_phenotyp | 0.88102843 |
120 | MP0003119_abnormal_digestive_system | 0.87859695 |
121 | MP0008007_abnormal_cellular_replicative | 0.87455375 |
122 | MP0002933_joint_inflammation | 0.86889682 |
123 | MP0000428_abnormal_craniofacial_morphol | 0.86889410 |
124 | MP0008770_decreased_survivor_rate | 0.86775609 |
125 | MP0003806_abnormal_nucleotide_metabolis | 0.85913541 |
126 | MP0001853_heart_inflammation | 0.85564836 |
127 | MP0002398_abnormal_bone_marrow | 0.84062816 |
128 | MP0002138_abnormal_hepatobiliary_system | 0.83835448 |
129 | MP0000358_abnormal_cell_content/ | 0.82467061 |
130 | MP0002114_abnormal_axial_skeleton | 0.80998820 |
131 | MP0000762_abnormal_tongue_morphology | 0.79906463 |
132 | MP0002429_abnormal_blood_cell | 0.79813908 |
133 | MP0009785_altered_susceptibility_to | 0.79631181 |
134 | MP0004510_myositis | 0.79504945 |
135 | MP0005390_skeleton_phenotype | 0.78752802 |
136 | MP0000432_abnormal_head_morphology | 0.78723079 |
137 | MP0003091_abnormal_cell_migration | 0.77653654 |
138 | MP0000015_abnormal_ear_pigmentation | 0.77159128 |
139 | MP0005384_cellular_phenotype | 0.76605796 |
140 | MP0009765_abnormal_xenobiotic_induced | 0.76189099 |
141 | MP0003315_abnormal_perineum_morphology | 0.75021756 |
142 | MP0001348_abnormal_lacrimal_gland | 0.74932397 |
143 | MP0002877_abnormal_melanocyte_morpholog | 0.74635225 |
144 | MP0001800_abnormal_humoral_immune | 0.73309324 |
145 | MP0001663_abnormal_digestive_system | 0.73062888 |
146 | MP0008789_abnormal_olfactory_epithelium | 0.72637837 |
147 | MP0000049_abnormal_middle_ear | 0.72381750 |
148 | MP0003795_abnormal_bone_structure | 0.70942786 |
149 | MP0003935_abnormal_craniofacial_develop | 0.70110706 |
150 | MP0005076_abnormal_cell_differentiation | 0.69581222 |
151 | MP0000716_abnormal_immune_system | 0.69470625 |
152 | MP0000703_abnormal_thymus_morphology | 0.69302961 |
153 | MP0003828_pulmonary_edema | 0.69208077 |
154 | MP0009703_decreased_birth_body | 0.69079104 |
155 | MP0003453_abnormal_keratinocyte_physiol | 0.68021109 |
156 | MP0003690_abnormal_glial_cell | 0.67284496 |
157 | MP0004133_heterotaxia | 0.65584767 |
158 | MP0002233_abnormal_nose_morphology | 0.65201468 |
159 | MP0000249_abnormal_blood_vessel | 0.63595940 |
160 | MP0010307_abnormal_tumor_latency | 0.63125916 |
161 | MP0000609_abnormal_liver_physiology | 0.60737077 |
162 | MP0005319_abnormal_enzyme/_coenzyme | 0.58836053 |
163 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57668236 |
164 | MP0006054_spinal_hemorrhage | 0.57656526 |
165 | MP0005621_abnormal_cell_physiology | 0.51359124 |
166 | MP0000371_diluted_coat_color | 0.50224231 |
167 | MP0009115_abnormal_fat_cell | 0.48536858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bilateral microphthalmos (HP:0007633) | 6.34881424 |
2 | Hypochromic microcytic anemia (HP:0004840) | 5.62044711 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.14879646 |
4 | Recurrent abscess formation (HP:0002722) | 5.12505798 |
5 | Multiple enchondromatosis (HP:0005701) | 4.88790284 |
6 | Hepatoblastoma (HP:0002884) | 4.71733989 |
7 | Abnormality of macrophages (HP:0004311) | 4.68701483 |
8 | Myositis (HP:0100614) | 4.52600168 |
9 | Rib fusion (HP:0000902) | 4.36313556 |
10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.30860892 |
11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.30860892 |
12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.30860892 |
13 | Ependymoma (HP:0002888) | 4.27402420 |
14 | Stomatitis (HP:0010280) | 4.19202807 |
15 | Abnormality of the lower motor neuron (HP:0002366) | 4.17981881 |
16 | Orchitis (HP:0100796) | 4.00913772 |
17 | Recurrent fungal infections (HP:0002841) | 3.98964119 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 3.97667410 |
19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87575996 |
20 | Optic neuritis (HP:0100653) | 3.83727759 |
21 | Retrobulbar optic neuritis (HP:0100654) | 3.83727759 |
22 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.76535000 |
23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.68887173 |
24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.68887173 |
25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62919721 |
26 | Recurrent skin infections (HP:0001581) | 3.62511205 |
27 | Recurrent viral infections (HP:0004429) | 3.59693580 |
28 | Neoplasm of striated muscle (HP:0009728) | 3.54175029 |
29 | Obstructive lung disease (HP:0006536) | 3.53645668 |
30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53645668 |
31 | Rhabdomyosarcoma (HP:0002859) | 3.52962911 |
32 | Meningitis (HP:0001287) | 3.50070217 |
33 | Increased cerebral lipofuscin (HP:0011813) | 3.43375821 |
34 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.32754380 |
35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29474382 |
36 | Chromsome breakage (HP:0040012) | 3.28657393 |
37 | Gastrointestinal infarctions (HP:0005244) | 3.28630223 |
38 | Dysostosis multiplex (HP:0000943) | 3.15643387 |
39 | T lymphocytopenia (HP:0005403) | 3.14925222 |
40 | Fused cervical vertebrae (HP:0002949) | 3.12735976 |
41 | Vacuolated lymphocytes (HP:0001922) | 3.11934347 |
42 | Vasculitis (HP:0002633) | 3.09774979 |
43 | Embryonal renal neoplasm (HP:0011794) | 3.07599225 |
44 | Hemoptysis (HP:0002105) | 3.01793022 |
45 | Pulmonary infiltrates (HP:0002113) | 2.98623953 |
46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97971277 |
47 | Testicular atrophy (HP:0000029) | 2.96120240 |
48 | Loss of speech (HP:0002371) | 2.95551974 |
49 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.93160247 |
50 | Astrocytoma (HP:0009592) | 2.92482428 |
51 | Abnormality of the astrocytes (HP:0100707) | 2.92482428 |
52 | Hypochromic anemia (HP:0001931) | 2.92413290 |
53 | Encephalitis (HP:0002383) | 2.90887176 |
54 | Short humerus (HP:0005792) | 2.89892134 |
55 | Agammaglobulinemia (HP:0004432) | 2.89650598 |
56 | Abnormality of T cell number (HP:0011839) | 2.89106980 |
57 | Cellulitis (HP:0100658) | 2.87434478 |
58 | Pustule (HP:0200039) | 2.85961505 |
59 | Trismus (HP:0000211) | 2.84966582 |
60 | Ragged-red muscle fibers (HP:0003200) | 2.83891031 |
61 | Rectovaginal fistula (HP:0000143) | 2.81961782 |
62 | Rectal fistula (HP:0100590) | 2.81961782 |
63 | Amyotrophic lateral sclerosis (HP:0007354) | 2.81449227 |
64 | Panhypogammaglobulinemia (HP:0003139) | 2.77209441 |
65 | Chest pain (HP:0100749) | 2.76233080 |
66 | Urticaria (HP:0001025) | 2.73201715 |
67 | Colitis (HP:0002583) | 2.72763731 |
68 | Spontaneous hematomas (HP:0007420) | 2.70791985 |
69 | Reduced antithrombin III activity (HP:0001976) | 2.69951467 |
70 | Keratoconjunctivitis sicca (HP:0001097) | 2.69799299 |
71 | Abnormality of the salivary glands (HP:0010286) | 2.67862659 |
72 | Increased IgE level (HP:0003212) | 2.65007156 |
73 | Abnormal lung lobation (HP:0002101) | 2.63702021 |
74 | Abnormal cartilage morphology (HP:0002763) | 2.63309043 |
75 | Thrombocytosis (HP:0001894) | 2.63211562 |
76 | Intestinal fistula (HP:0100819) | 2.61382938 |
77 | Autoimmune thrombocytopenia (HP:0001973) | 2.60248846 |
78 | Granulocytopenia (HP:0001913) | 2.60235245 |
79 | Preauricular skin tag (HP:0000384) | 2.58662154 |
80 | Meckel diverticulum (HP:0002245) | 2.57957798 |
81 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.56835968 |
82 | Hypoplasia of the fovea (HP:0007750) | 2.56835968 |
83 | Abnormality of T cells (HP:0002843) | 2.54769041 |
84 | Inflammation of the large intestine (HP:0002037) | 2.54444694 |
85 | Vaginal fistula (HP:0004320) | 2.53378923 |
86 | Leukocytosis (HP:0001974) | 2.52438684 |
87 | Gastrointestinal inflammation (HP:0004386) | 2.51952282 |
88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49262709 |
89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49262709 |
90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49262709 |
91 | Arterial thrombosis (HP:0004420) | 2.48360488 |
92 | Fatigue (HP:0012378) | 2.47090460 |
93 | Osteomyelitis (HP:0002754) | 2.44964495 |
94 | Keratoconjunctivitis (HP:0001096) | 2.43812511 |
95 | Amyloidosis (HP:0011034) | 2.43698838 |
96 | Increased IgM level (HP:0003496) | 2.43080352 |
97 | Partial duplication of thumb phalanx (HP:0009944) | 2.41506587 |
98 | Abnormality of the ileum (HP:0001549) | 2.41327194 |
99 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.40353305 |
100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38052089 |
101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37563791 |
102 | Mucopolysacchariduria (HP:0008155) | 2.37563791 |
103 | Skin tags (HP:0010609) | 2.35860833 |
104 | Epistaxis (HP:0000421) | 2.35793564 |
105 | Short 5th finger (HP:0009237) | 2.34718291 |
106 | Prolonged bleeding time (HP:0003010) | 2.32647887 |
107 | Glossoptosis (HP:0000162) | 2.31930943 |
108 | Anomalous pulmonary venous return (HP:0010772) | 2.31724623 |
109 | Progressive muscle weakness (HP:0003323) | 2.31386452 |
110 | Impulsivity (HP:0100710) | 2.30034934 |
111 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29500584 |
112 | Increased serum ferritin (HP:0003281) | 2.27771378 |
113 | Bifid tongue (HP:0010297) | 2.27334506 |
114 | Cheilitis (HP:0100825) | 2.26487889 |
115 | Abnormality of the prostate (HP:0008775) | 2.24913443 |
116 | Abnormality of chromosome segregation (HP:0002916) | 2.19122934 |
117 | Abnormality of T cell physiology (HP:0011840) | 2.19032619 |
118 | Hand muscle atrophy (HP:0009130) | 2.18389332 |
119 | Horizontal nystagmus (HP:0000666) | 2.17989749 |
120 | Systemic lupus erythematosus (HP:0002725) | 2.17824063 |
121 | Gingival bleeding (HP:0000225) | 2.17403725 |
122 | Hypergammaglobulinemia (HP:0010702) | 2.16902511 |
123 | Large earlobe (HP:0009748) | 2.16735840 |
124 | Partial duplication of the phalanx of hand (HP:0009999) | 2.16711215 |
125 | Myelodysplasia (HP:0002863) | 2.15277239 |
126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14427142 |
127 | Upper motor neuron abnormality (HP:0002127) | 2.11955895 |
128 | Autoimmune hemolytic anemia (HP:0001890) | 2.11570969 |
129 | Amaurosis fugax (HP:0100576) | 2.11466351 |
130 | Peritonitis (HP:0002586) | 2.11101321 |
131 | Hematochezia (HP:0002573) | 2.10536207 |
132 | Viral hepatitis (HP:0006562) | 2.10482209 |
133 | Hepatosplenomegaly (HP:0001433) | 2.10418710 |
134 | Glioma (HP:0009733) | 2.10173621 |
135 | Microretrognathia (HP:0000308) | 2.09559094 |
136 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.09515758 |
137 | Abnormality of the pleura (HP:0002103) | 2.08962045 |
138 | Aplastic anemia (HP:0001915) | 2.08805872 |
139 | Eosinophilia (HP:0001880) | 2.07336948 |
140 | Gangrene (HP:0100758) | 2.07079844 |
141 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06268441 |
142 | Interstitial pulmonary disease (HP:0006530) | 2.05432392 |
143 | Medulloblastoma (HP:0002885) | 2.04528358 |
144 | Shawl scrotum (HP:0000049) | 2.03845250 |
145 | Pulmonary embolism (HP:0002204) | 2.03693048 |
146 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.03556090 |
147 | Petechiae (HP:0000967) | 2.02886675 |
148 | Episodic fever (HP:0001954) | 2.02040883 |
149 | Pseudobulbar signs (HP:0002200) | 2.02030701 |
150 | Tongue fasciculations (HP:0001308) | 2.01899951 |
151 | Generalized hypotonia (HP:0001290) | 2.01703288 |
152 | Glomerulopathy (HP:0100820) | 2.01031418 |
153 | Small intestinal stenosis (HP:0012848) | 2.00541581 |
154 | Duodenal stenosis (HP:0100867) | 2.00541581 |
155 | Combined immunodeficiency (HP:0005387) | 2.00496010 |
156 | Abnormality of iron homeostasis (HP:0011031) | 2.00110496 |
157 | Renal duplication (HP:0000075) | 1.99294073 |
158 | Myocardial infarction (HP:0001658) | 1.98650385 |
159 | Increased connective tissue (HP:0009025) | 1.98635886 |
160 | Anorexia (HP:0002039) | 1.98170860 |
161 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.98157358 |
162 | Supernumerary spleens (HP:0009799) | 1.97905017 |
163 | Selective tooth agenesis (HP:0001592) | 1.97566010 |
164 | Preauricular pit (HP:0004467) | 1.97145841 |
165 | Periauricular skin pits (HP:0100277) | 1.97145841 |
166 | Restrictive lung disease (HP:0002091) | 1.96816453 |
167 | Lymphopenia (HP:0001888) | 1.96788954 |
168 | Abnormality of the musculature of the hand (HP:0001421) | 1.96091816 |
169 | Spondylolisthesis (HP:0003302) | 1.95445008 |
170 | Ulnar bowing (HP:0003031) | 1.95273889 |
171 | Chronic diarrhea (HP:0002028) | 1.94948464 |
172 | Skin ulcer (HP:0200042) | 1.94365108 |
173 | Polyneuropathy (HP:0001271) | 1.93680069 |
174 | Sepsis (HP:0100806) | 1.93555042 |
175 | Vertebral fusion (HP:0002948) | 1.93325686 |
176 | Gastrointestinal stroma tumor (HP:0100723) | 1.93156035 |
177 | Abnormality of the fovea (HP:0000493) | 1.92496431 |
178 | Abnormality of the pulmonary veins (HP:0011718) | 1.92440536 |
179 | Missing ribs (HP:0000921) | 1.91902165 |
180 | Hypopigmentation of the fundus (HP:0007894) | 1.91891889 |
181 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.91555235 |
182 | Villous atrophy (HP:0011473) | 1.91555235 |
183 | Gingivitis (HP:0000230) | 1.90729275 |
184 | Nasal polyposis (HP:0100582) | 1.88759843 |
185 | Pendular nystagmus (HP:0012043) | 1.84930676 |
186 | Premature ovarian failure (HP:0008209) | 1.84780453 |
187 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.84517652 |
188 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.83811254 |
189 | Resting tremor (HP:0002322) | 1.83320323 |
190 | Eczematoid dermatitis (HP:0000976) | 1.83211459 |
191 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.83140574 |
192 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.82639011 |
193 | Muscle fibrillation (HP:0010546) | 1.82591626 |
194 | Angiofibromas (HP:0010615) | 1.81708301 |
195 | Adenoma sebaceum (HP:0009720) | 1.81708301 |
196 | Atresia of the external auditory canal (HP:0000413) | 1.80374099 |
197 | Absent frontal sinuses (HP:0002688) | 1.78046216 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 7.87315152 |
2 | ERN1 | 5.08867113 |
3 | GRK6 | 4.34570037 |
4 | GRK5 | 3.95731788 |
5 | RIPK4 | 3.57946027 |
6 | MAP3K14 | 2.93638747 |
7 | CSF1R | 2.93398230 |
8 | STK10 | 2.92765419 |
9 | TYK2 | 2.91794640 |
10 | MAP3K13 | 2.72636200 |
11 | PRPF4B | 2.70996434 |
12 | TTK | 2.54245322 |
13 | TGFBR2 | 2.46730041 |
14 | GRK1 | 2.42652513 |
15 | MATK | 2.17024882 |
16 | ADRBK2 | 2.13299011 |
17 | FES | 2.06133077 |
18 | JAK3 | 2.05085854 |
19 | TYRO3 | 2.01565216 |
20 | TBK1 | 1.97688072 |
21 | TAOK3 | 1.95167154 |
22 | IRAK3 | 1.92060051 |
23 | MOS | 1.90729346 |
24 | IKBKE | 1.77420146 |
25 | TXK | 1.76061369 |
26 | CDK7 | 1.74815539 |
27 | MAPK7 | 1.74203922 |
28 | PAK4 | 1.74041661 |
29 | SYK | 1.66013762 |
30 | PRKG2 | 1.59895028 |
31 | GRK7 | 1.59121582 |
32 | CSK | 1.40468988 |
33 | JAK1 | 1.39721284 |
34 | TNK2 | 1.39021910 |
35 | MAP3K10 | 1.38867618 |
36 | NEK2 | 1.34355769 |
37 | NME2 | 1.33025725 |
38 | CDC7 | 1.32913735 |
39 | LYN | 1.30575249 |
40 | BMPR2 | 1.30455268 |
41 | WNK1 | 1.30145299 |
42 | CHEK2 | 1.25509824 |
43 | TESK2 | 1.23505408 |
44 | TEC | 1.20188082 |
45 | PLK1 | 1.19336938 |
46 | WEE1 | 1.16856787 |
47 | LCK | 1.15417295 |
48 | EPHA2 | 1.13573000 |
49 | SMG1 | 1.09720265 |
50 | CAMK4 | 1.08036297 |
51 | JAK2 | 1.06115403 |
52 | ALK | 1.05750399 |
53 | MAP3K1 | 0.99345345 |
54 | CDC42BPA | 0.99229819 |
55 | FGFR3 | 0.99208638 |
56 | MARK3 | 0.97461694 |
57 | HIPK2 | 0.95319444 |
58 | BUB1 | 0.94890202 |
59 | SIK3 | 0.94013852 |
60 | IRAK1 | 0.93966253 |
61 | MARK2 | 0.90857621 |
62 | MAP2K6 | 0.88920945 |
63 | KSR2 | 0.88233917 |
64 | NTRK1 | 0.87693305 |
65 | CDK6 | 0.84477790 |
66 | MAP2K3 | 0.80151723 |
67 | CHEK1 | 0.79631300 |
68 | BLK | 0.76664907 |
69 | ADRBK1 | 0.74669759 |
70 | PDK1 | 0.74292270 |
71 | TRIB3 | 0.73813685 |
72 | IRAK4 | 0.73082517 |
73 | PIK3CG | 0.72593085 |
74 | RPS6KB2 | 0.70808489 |
75 | CDK4 | 0.69162163 |
76 | PRKD2 | 0.66383292 |
77 | CHUK | 0.65941570 |
78 | IRAK2 | 0.64932364 |
79 | PTK2 | 0.64239940 |
80 | MAP3K8 | 0.63637894 |
81 | PDPK1 | 0.62762171 |
82 | ITK | 0.62046399 |
83 | MAP2K4 | 0.61900473 |
84 | MAP3K9 | 0.61626669 |
85 | BRD4 | 0.61157085 |
86 | MAP4K1 | 0.59802175 |
87 | MTOR | 0.59660249 |
88 | NEK1 | 0.59174493 |
89 | AKT2 | 0.58842753 |
90 | NEK9 | 0.58100806 |
91 | MAPK11 | 0.55926485 |
92 | YES1 | 0.53795969 |
93 | FGFR4 | 0.52518949 |
94 | AURKA | 0.51708675 |
95 | AURKB | 0.51511181 |
96 | MAPKAPK3 | 0.51477664 |
97 | TTN | 0.51191204 |
98 | LRRK2 | 0.50954093 |
99 | HCK | 0.49783997 |
100 | ICK | 0.49082899 |
101 | CDK2 | 0.48915221 |
102 | PAK1 | 0.46333572 |
103 | TAOK1 | 0.46048880 |
104 | TAOK2 | 0.45351267 |
105 | RPS6KC1 | 0.45041735 |
106 | RPS6KL1 | 0.45041735 |
107 | DYRK3 | 0.44984752 |
108 | MAPK12 | 0.44519168 |
109 | MAP3K7 | 0.44234077 |
110 | MAP2K2 | 0.43888122 |
111 | EPHB1 | 0.43657865 |
112 | PIM1 | 0.43542343 |
113 | SIK1 | 0.42749714 |
114 | MAP3K5 | 0.42540006 |
115 | STK4 | 0.42318158 |
116 | LATS2 | 0.42078320 |
117 | RAF1 | 0.42048177 |
118 | EIF2AK2 | 0.41155817 |
119 | MELK | 0.41097296 |
120 | CAMKK2 | 0.40072009 |
121 | MAPK4 | 0.39618434 |
122 | BTK | 0.38712542 |
123 | ACVR1B | 0.38070531 |
124 | ZAP70 | 0.37745837 |
125 | FLT3 | 0.37330875 |
126 | BMX | 0.36800128 |
127 | MAP3K6 | 0.36391803 |
128 | PKN2 | 0.36389191 |
129 | PIM2 | 0.36256837 |
130 | MAP3K3 | 0.35603019 |
131 | CAMK1D | 0.35516829 |
132 | FYN | 0.35289831 |
133 | AKT3 | 0.35216375 |
134 | DYRK1B | 0.35126014 |
135 | PRKCD | 0.34834921 |
136 | PRKCQ | 0.34458084 |
137 | PRKCI | 0.34199231 |
138 | ATM | 0.33896045 |
139 | RPS6KA6 | 0.33820766 |
140 | CDK9 | 0.33300836 |
141 | ATR | 0.32198014 |
142 | RIPK1 | 0.32190667 |
143 | IGF1R | 0.31831885 |
144 | IKBKB | 0.29677069 |
145 | CLK1 | 0.28144436 |
146 | SCYL2 | 0.27470505 |
147 | EEF2K | 0.26772671 |
148 | BRSK2 | 0.25542434 |
149 | MAPKAPK2 | 0.25230879 |
150 | KDR | 0.24768460 |
151 | FGR | 0.24498928 |
152 | MAP3K11 | 0.23721142 |
153 | MAPK1 | 0.21758465 |
154 | KIT | 0.20888695 |
155 | PDGFRA | 0.19371453 |
156 | CDK1 | 0.19194719 |
157 | TRPM7 | 0.18844097 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.42099341 |
2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.09279092 |
3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.74171074 |
4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.02317991 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.90409845 |
6 | DNA replication_Homo sapiens_hsa03030 | 2.78904752 |
7 | Asthma_Homo sapiens_hsa05310 | 2.63670804 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.57601033 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56589815 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.51204089 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35219492 |
12 | Galactose metabolism_Homo sapiens_hsa00052 | 2.18975617 |
13 | Mismatch repair_Homo sapiens_hsa03430 | 2.08873218 |
14 | RNA transport_Homo sapiens_hsa03013 | 2.06553477 |
15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04613807 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01543744 |
17 | Cell cycle_Homo sapiens_hsa04110 | 1.95067041 |
18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.90461876 |
19 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.85111789 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84209833 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83532032 |
22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65493431 |
23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64597292 |
24 | Measles_Homo sapiens_hsa05162 | 1.63973156 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.63646013 |
26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56538726 |
27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.56019677 |
28 | Base excision repair_Homo sapiens_hsa03410 | 1.54023740 |
29 | Malaria_Homo sapiens_hsa05144 | 1.52907431 |
30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.52600310 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50497473 |
32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.48447082 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48134380 |
34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48004517 |
35 | Homologous recombination_Homo sapiens_hsa03440 | 1.47853496 |
36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.45117732 |
37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44186636 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42132134 |
39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.41639368 |
40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.40416638 |
41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36091169 |
42 | Spliceosome_Homo sapiens_hsa03040 | 1.33911089 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32606962 |
44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31342792 |
45 | Pertussis_Homo sapiens_hsa05133 | 1.29728494 |
46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29039422 |
47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27106016 |
48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.26796154 |
49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23921086 |
50 | Phagosome_Homo sapiens_hsa04145 | 1.23443827 |
51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21708700 |
52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21005958 |
53 | Ribosome_Homo sapiens_hsa03010 | 1.19917491 |
54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14444632 |
55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12587112 |
56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12111576 |
57 | Bladder cancer_Homo sapiens_hsa05219 | 1.08506315 |
58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07365224 |
59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04847247 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04463304 |
61 | Hepatitis C_Homo sapiens_hsa05160 | 1.04400206 |
62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.03368146 |
63 | RNA degradation_Homo sapiens_hsa03018 | 1.02621920 |
64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95597794 |
65 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.93235225 |
66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92999494 |
67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92950171 |
68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87123871 |
69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86764858 |
70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86176358 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.85610757 |
72 | Salmonella infection_Homo sapiens_hsa05132 | 0.85172756 |
73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84686293 |
74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81195475 |
75 | Apoptosis_Homo sapiens_hsa04210 | 0.77525037 |
76 | Pathways in cancer_Homo sapiens_hsa05200 | 0.77333831 |
77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76237672 |
78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75201622 |
79 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.73378243 |
80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72993294 |
81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71711391 |
82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70405528 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70266933 |
84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69836339 |
85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66822767 |
86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66648023 |
87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65571908 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64882067 |
89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63876371 |
90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60563572 |
91 | Amoebiasis_Homo sapiens_hsa05146 | 0.59828883 |
92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59800509 |
93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59469560 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58961846 |
95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58716334 |
96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58404963 |
97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58154298 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55251594 |
99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54674612 |
100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54247110 |
101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53872090 |
102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53628502 |
103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52589170 |
104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52328282 |
105 | Legionellosis_Homo sapiens_hsa05134 | 0.52200613 |
106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52126242 |
107 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51513129 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51175694 |
109 | RNA polymerase_Homo sapiens_hsa03020 | 0.51169332 |
110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50634476 |
111 | Shigellosis_Homo sapiens_hsa05131 | 0.50346060 |
112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47683023 |
113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47076503 |
114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46032180 |
115 | Adherens junction_Homo sapiens_hsa04520 | 0.45994960 |
116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45761903 |
117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44724247 |
118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44404111 |
119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43456589 |
120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42709424 |
121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42138531 |
122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42094227 |
123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41897566 |
124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41259764 |
125 | Prostate cancer_Homo sapiens_hsa05215 | 0.40389003 |
126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39343788 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.38144477 |
128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38028529 |
129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37314355 |
130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36998821 |
131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36284402 |
132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36175782 |
133 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.35860446 |
134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35338402 |
135 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34919113 |
136 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34362322 |
137 | Influenza A_Homo sapiens_hsa05164 | 0.33669061 |
138 | Hepatitis B_Homo sapiens_hsa05161 | 0.33379166 |
139 | Insulin resistance_Homo sapiens_hsa04931 | 0.32445933 |
140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32157825 |
141 | Tuberculosis_Homo sapiens_hsa05152 | 0.31588627 |
142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31581846 |
143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31397803 |
144 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.30633764 |
145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30084168 |
146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26753147 |
147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24475806 |
148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24330722 |